Immuneering Corp (IMRX)
2.48
+0.11
(+4.64%)
USD |
NASDAQ |
Oct 04, 16:00
2.48
0.00 (0.00%)
After-Hours: 20:00
Immuneering Shareholders Equity (Annual): 90.58M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 90.58M |
December 31, 2022 | 109.85M |
December 31, 2021 | 155.98M |
Date | Value |
---|---|
December 31, 2020 | -22.48M |
December 31, 2019 | -6.528M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
-22.48M
Minimum
2020
155.98M
Maximum
2021
65.48M
Average
90.58M
Median
2023
Shareholders Equity (Annual) Benchmarks
Singular Genomics Systems Inc | 179.01M |
Biomarin Pharmaceutical Inc | 4.952B |
Integra Lifesciences Holdings Corp | 1.588B |
Eton Pharmaceuticals Inc | 15.48M |
Tenon Medical Inc | 0.778M |